|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
| The drug delivery sector started as a separate industry in the late 1960s when companies such as Elan and Alza began to develop oral controlled release formulations for companies in the mainstream pharmaceutical sector. Since then, drug delivery companies have developed a wide panel of formulations to help improve efficacy, safety and efficiency of therapeutics to answer the needs of the pharmaceutical industry. In particular controlled release systems are being developed that will lead to more efficient processing and targeting of drugs in the future. Drug delivery technology is now being rapidly transformed from a minor market segment into a US$41 billion sector (1), which accounts for 12.5 per cent of world total pharmaceutical sales and dominates the pharmaceutical and health care industries. Pharmaceutical markets are increasingly driven by patient needs and demand is growing for drug delivery technologies that are more convenient for patients and thus improve compliance. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
MipTec, October 14 – 16, 2008, Switzerland
MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com
More info >> |
|
 |
